CLIA lab

CLIA 05D2263098: Chemidox Clinical Trials

Lancaster, CA. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 05D2263098 belongs to Chemidox Clinical Trials in Lancaster, CA.

Certificate of Waiver, effective June 22, 2026, expires June 21, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
June 22, 2026
Certificate expiration
June 21, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
June 22, 2022
Facility type
Other
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory
Directly affiliated labs
1

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
05D2263098
Lab name
Chemidox Clinical Trials
Address
44404 16th St W Ste 101, Lancaster, CA 93534
Phone
(833) 324-3643
Fax
(717) 837-5460

Annual test volume the lab reported

Waived tests
500

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Affiliated CLIA numbers

Other labs in Lancaster, CA

Related

Questions

What is the CLIA number for Chemidox Clinical Trials in Lancaster?

05D2263098, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Chemidox Clinical Trials hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 05D2263098 expire?

The CMS file lists June 21, 2028 as the certificate expiration date; the certificate took effect June 22, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.